Colgate-Palmolive
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Colgate-Palmolive's revenues will grow 2.3% and EPS will grow 6.5%.
The average estimate for revenue is $4.30 billion. On the bottom line, the average EPS estimate is $1.32.
Revenue details
Last quarter, Colgate-Palmolive logged revenue of $4.29 billion. GAAP reported sales were 2.7% higher than the prior-year quarter's $4.17 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $1.41. GAAP EPS of $1.26 for Q4 were 4.1% higher than the prior-year quarter's $1.21 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 58.5%, 80 basis points better than the prior-year quarter. Operating margin was 23.9%, 70 basis points better than the prior-year quarter. Net margin was 14.0%, 10 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $17.79 billion. The average EPS estimate is $5.74.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,314 members out of 1,363 rating the stock outperform, and 49 members rating it underperform. Among 503 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 494 give Colgate-Palmolive a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Colgate-Palmolive is hold, with an average price target of $111.32.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Colgate-Palmolive. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Colgate-Palmolive to My Watchlist.